{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:11Z","timestamp":1786984331619,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ajog.2016.06.023","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T15:25:08Z","timestamp":1467041108000},"page":"423-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Antenatal corticosteroids beyond 34 weeks gestation: What\u00a0do\u00a0we\u00a0do\u00a0now?"],"prefix":"10.1016","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8482-4802","authenticated-orcid":false,"given":"Beena D.","family":"Kamath-Rayne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Rozance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan H.","family":"Jobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2016.06.023_bib1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A\u00a0controlled trial of\u00a0antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins","year":"1972","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2016.06.023_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3476(05)80502-5","article-title":"Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial: American Exosurf Pediatric Study Group 1","volume":"118","author":"Corbet","year":"1991","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ajog.2016.06.023_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-9378(95)90222-8","article-title":"Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994","volume":"173","author":"Crowley","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.023_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0002-9378(95)90223-6","article-title":"Meta-analysis of randomized controlled trials of antenatal corticosteroid for the prevention of respiratory distress syndrome: discussion","volume":"173","author":"Sinclair","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.023_bib5","first-page":"1","article-title":"Effect of corticosteroids for fetal maturation on perinatal outcomes","volume":"12","year":"1994","journal-title":"NIH Consensus Statement"},{"key":"10.1016\/j.ajog.2016.06.023_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.1995.03520290065031","article-title":"Effect of corticosteroids for fetal maturation on perinatal outcomes: NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2016.06.023_bib7","unstructured":"American College of Obstetricians and Gynecologists. Practice Advisory: Antenatal Corticosteroid Administration in the Late Preterm Period. 2016. Available at: https:\/\/www.acog.org\/About-ACOG\/News-Room\/Practice-Advisories\/Practice-Advisory-Antenatal-Corticosteroid-Administration-in-the-Late-Preterm-Period#. Vwwshb6RnkA.email. Accessed 4\/8\/16."},{"key":"10.1016\/j.ajog.2016.06.023_bib8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/AOG.0b013e31820eee00","article-title":"ACOG Committee Opinion No. 475: antenatal corticosteroid therapy for fetal maturation","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.023_bib9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/AOG.0b013e31824ea4b2","article-title":"Antenatal steroids for treatment of fetal lung immaturity after 34 weeks of gestation: an evaluation of neonatal outcomes","volume":"119","author":"Kamath-Rayne","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.023_bib10","doi-asserted-by":"crossref","first-page":"222.e1","DOI":"10.1016\/j.ajog.2012.06.019","article-title":"Should patients with documented fetal lung immaturity after 34 weeks of gestation be treated with steroids?","volume":"207","author":"Yinon","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.023_bib11","doi-asserted-by":"crossref","first-page":"47.e1","DOI":"10.1016\/j.ajog.2010.02.038","article-title":"Administration of steroids after 34 weeks of gestation enhances fetal lung maturity profiles","volume":"203","author":"Shanks","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.023_bib12","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/bmj.38547.416493.06","article-title":"Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial","volume":"331","author":"Stutchfield","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2016.06.023_bib13","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3109\/14767058.2014.958461","article-title":"Antenatal steroids at 37 weeks, does it reduce neonatal respiratory morbidity? A randomized trial","volume":"28","author":"Ahmed","year":"2015","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2016.06.023_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejogrb.2016.01.026","article-title":"Antenatal corticosteroid administration before elective caesarean section at term to prevent neonatal respiratory morbidity: a randomized controlled trial","volume":"199","author":"Nada","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2016.06.023_bib15","first-page":"CD004454","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"3","author":"Roberts","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ajog.2016.06.023_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000295898","article-title":"The effect of antenatal steroids on fetal lung maturation between the 34th and 36th week of pregnancy","volume":"70","author":"Balci","year":"2010","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2016.06.023_bib17","doi-asserted-by":"crossref","first-page":"d1696","DOI":"10.1136\/bmj.d1696","article-title":"Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial","volume":"342","author":"Porto","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2016.06.023_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/NPM-16915086","article-title":"Antenatal corticosteroids in\u00a0the late preterm period: a prospective cohort\u00a0study","volume":"9","author":"Ramadan","year":"2016","journal-title":"J\u00a0Neonatal Perinatal Med"},{"key":"10.1016\/j.ajog.2016.06.023_bib19","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal betamethasone for women at risk for late preterm delivery","volume":"374","author":"Gyamfi-Bannerman","year":"2016","journal-title":"NEngl J Med"},{"key":"10.1016\/j.ajog.2016.06.023_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ajog.2016.03.013","article-title":"SMFM statement: implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery","volume":"215","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.023_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.clp.2013.09.006","article-title":"Steroids and injury to the developing brain: net harm or net benefit?","volume":"41","author":"Malaeb","year":"2014","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.ajog.2016.06.023_bib22","first-page":"CD001145","article-title":"Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants","volume":"1","author":"Halliday","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2016.06.023_bib23","first-page":"CD001146","article-title":"Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants","volume":"1","author":"Halliday","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2016.06.023_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clp.2011.12.017","article-title":"Evidence-based neonatal pharmacotherapy: postnatal corticosteroids","volume":"39","author":"Watterberg","year":"2012","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.ajog.2016.06.023_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1210\/jc.2014-2843","article-title":"Antenatal glucocorticoid treatment and polymorphisms of the glucocorticoid and mineralocorticoid receptors are associated with IQ and behavior in young adults born very preterm","volume":"100","author":"van der Voorn","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2016.06.023_bib26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1053\/j.semperi.2014.08.018","article-title":"Antenatal corticosteroid therapy: current strategies and identifying mediators and markers for response","volume":"38","author":"Falah","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2016.06.023_bib27","first-page":"240","article-title":"The clinical use of corticosteroids in pregnancy","volume":"22","author":"Kemp","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2016.06.023_bib28","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/AOG.0000000000000748","article-title":"Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta-analysis","volume":"125","author":"Sotiriadis","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.023_bib29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1542\/peds.2013-1131","article-title":"Late preterm infants: near term but still in a critical developmental time period","volume":"132","author":"Kugelman","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2016.06.023_bib30","doi-asserted-by":"crossref","first-page":"F195","DOI":"10.1136\/archdischild-2012-303157","article-title":"Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial)","volume":"98","author":"Stutchfield","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ajog.2016.06.023_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/14767058.2013.832750","article-title":"The association of antenatal corticosteroids with neonatal hypoglycemia and hyperbilirubinemia","volume":"27","author":"Pettit","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2016.06.023_bib32","first-page":"138","article-title":"Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation","volume":"20","author":"Sifianou","year":"2015","journal-title":"J\u00a0Pediatr Pharmacol Ther"},{"key":"10.1016\/j.ajog.2016.06.023_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1017\/S2040174414000579","article-title":"Antenatal glucocorticoids: where are we after forty years?","volume":"6","author":"McKinlay","year":"2015","journal-title":"J\u00a0Dev Orig Health Dis"},{"key":"10.1016\/j.ajog.2016.06.023_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1042\/cs0980137","article-title":"Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children","volume":"98","author":"Doyle","year":"2000","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ajog.2016.06.023_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lfs.2015.04.005","article-title":"Prenatal dexamethasone-induced programmed hypertension and renal programming","volume":"132","author":"Sheen","year":"2015","journal-title":"Life Sci"},{"key":"10.1016\/j.ajog.2016.06.023_bib36","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1210\/jc.2012-1970","article-title":"Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children","volume":"97","author":"Alexander","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2016.06.023_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/bmjqs-2015-003984","article-title":"Reliable implementation of evidence: a qualitative study\u00a0of antenatal corticosteroid administration in Ohio hospitals","volume":"25","author":"Kaplan","year":"2016","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.ajog.2016.06.023_bib38","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1542\/peds.2014-2177","article-title":"Regional variation in antenatal corticosteroid use: a network-level quality improvement study","volume":"135","author":"Profit","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2016.06.023_bib39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/AOG.0000000000000629","article-title":"Trends in optimal, suboptimal, and questionably appropriate receipt of antenatal corticosteroid prophylaxis","volume":"125","author":"Razaz","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.023_bib40","first-page":"14","article-title":"Continuation of pregnancy after antenatal corticosteroid administration: opportunity for rescue?","volume":"55","author":"Davidson","year":"2010","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2016.06.023_bib41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1471-2393-14-272","article-title":"Association between gestational age at birth, antenatal corticosteroids, and outcomes at 5 years: multiple courses of antenatal corticosteroids for preterm birth study at 5 years of age (MACS-5)","volume":"14","author":"Asztalos","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2016.06.023_bib42","first-page":"1102","article-title":"Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5)","volume":"167","author":"Asztalos","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajog.2016.06.023_bib43","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(08)61929-7","article-title":"Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial","volume":"372","author":"Murphy","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2016.06.023_bib44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/AOG.0000000000000655","article-title":"Appropriate use of antenatal corticosteroid prophylaxis","volume":"125","author":"Goldenberg","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.06.023_bib45","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/1471-0528.13853","article-title":"Antenatal corticosteroids: a time for more careful scrutiny of the indications?","volume":"123","author":"Vidaeff","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2016.06.023_bib46","first-page":"CD006614","article-title":"Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term","volume":"4","author":"Sotiriadis","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2016.06.023_bib47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MOP.0000000000000319","article-title":"Neonatal hypoglycemia","volume":"28","author":"Adamkin","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.ajog.2016.06.023_bib48","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.jpeds.2015.02.045","article-title":"Re-evaluating \u201ctransitional neonatal hypoglycemia\u201d: mechanism and implications for management","volume":"166","author":"Stanley","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ajog.2016.06.023_bib49","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1542\/peds.2012-0079","article-title":"Neonatal morbidities and developmental delay in moderately preterm-born children","volume":"130","author":"Kerstjens","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2016.06.023_bib50","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.pcl.2009.03.009","article-title":"Health issues of the late preterm infant","volume":"56","author":"Ramachandrappa","year":"2009","journal-title":"Pediatr Clin North Am"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816303623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816303623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:09:39Z","timestamp":1757588979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937816303623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0002937816303623"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2016.06.023","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antenatal corticosteroids beyond 34 weeks gestation: What\u00a0do\u00a0we\u00a0do\u00a0now?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2016.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}